Laurent Dortet Selected Research

Colistin (Coly-Mycin)

6/2023	Two-site study on performances of a commercially available MALDI-TOF MS-based assay for the detection of colistin resistance in Escherichia coli.
1/2021	Detection of Colistin Resistance in Pseudomonas aeruginosa Using the MALDIxin Test on the Routine MALDI Biotyper Sirius Mass Spectrometer.
8/2020	Compassionate Use of Cefiderocol to Treat a Case of Prosthetic Joint Infection Due to Extensively Drug-Resistant Enterobacter hormaechei.
1/2020	Optimization of the MALDIxin test for the rapid identification of colistin resistance in Klebsiella pneumoniae using MALDI-TOF MS.
3/2019	Development and validation of a multiplex polymerase chain reaction assay for detection of the five families of plasmid-encoded colistin resistance.
1/2019	Development and Multicentric Validation of a Lateral Flow Immunoassay for Rapid Detection of MCR-1-Producing Enterobacteriaceae.
11/2018	Rapid detection of colistin resistance in Acinetobacter baumannii using MALDI-TOF-based lipidomics on intact bacteria.
10/2018	A 4.5-Year Within-Patient Evolution of a Colistin-Resistant Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Sequence Type 258.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurent Dortet Research Topics

Disease

28	Infections 01/2024 - 08/2011
4	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 01/2018
3	Communicable Diseases (Infectious Diseases) 11/2023 - 11/2015
3	COVID-19 01/2021 - 12/2020
2	Sepsis (Septicemia) 01/2024 - 04/2014
2	Cross Infection (Nosocomial Infection) 01/2020 - 01/2018
1	Gram-Negative Bacterial Infections 06/2023
1	Diabetes Mellitus 04/2022
1	Ventilator-Associated Pneumonia 03/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Pseudomonas Infections 01/2021
1	Fatigue 01/2021
1	Malaria 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Coronavirus Infections 01/2021
1	Drug-Related Side Effects and Adverse Reactions 08/2020
1	Wounds and Injuries (Trauma) 01/2019
1	Bacteremia 10/2018
1	Persistent Infection 01/2018
1	Endocarditis 11/2013
1	Bacterial Infections (Bacterial Infection) 11/2010

Drug/Important Bio-Agent (IBA)

11	carbapenemaseIBA 01/2023 - 04/2014
8	Colistin (Coly-Mycin)FDA Link 06/2023 - 10/2018
6	Carbapenems (Carbapenem Antibiotics)IBA 10/2022 - 01/2016
6	Anti-Bacterial Agents (Antibiotics)IBA 03/2022 - 01/2016
5	CefiderocolIBA 09/2023 - 08/2020
4	ceftazidime drug combination avibactamIBA 01/2024 - 01/2019
3	Aztreonam FDA LinkGeneric 01/2024 - 01/2019
3	tazobactam drug combination ceftolozaneIBA 01/2023 - 01/2019
2	Imipenem FDA Link 09/2023 - 01/2019
2	Linezolid (Zyvox)FDA Link 02/2022 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 12/2020
2	Immunoglobulin M (IgM)IBA 01/2021 - 12/2020
2	LactamsIBA 01/2020 - 01/2017
1	relebactamIBA 09/2023
1	meropenem and vaborbactamIBA 09/2023
1	Cephalosporins (Cephalosporin Antibiotics)IBA 08/2022
1	catechol (pyrocatechol)IBA 08/2022
1	Amdinocillin (Mecillinam)FDA Link 01/2022
1	AntigensIBA 01/2021
1	FluoroquinolonesIBA 01/2020
1	NitrofuransIBA 01/2020
1	Tazobactam FDA LinkGeneric 01/2019
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2019
1	Ceftazidime (Fortum)FDA LinkGeneric 01/2019
1	Meropenem (Merrem)FDA LinkGeneric 01/2019
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2019
1	avibactamIBA 01/2019
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2019
1	Polymyxins (Polymyxin)IBA 12/2018
1	Oxazolidinones (2 Oxazolidone)IBA 01/2018
1	Inosine Monophosphate (IMP)IBA 01/2018
1	AminoglycosidesIBA 01/2017
1	Vancomycin FDA LinkGeneric 11/2013
1	Daptomycin FDA Link 11/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2012
1	Virulence Factors (Pathogenicity Factors)IBA 08/2011
1	sortase AIBA 08/2011
1	Small Interfering RNA (siRNA)IBA 11/2010
1	Protein Isoforms (Isoforms)IBA 11/2010

Therapy/Procedure

3	Therapeutics 01/2024 - 11/2018
1	Critical Care (Surgical Intensive Care) 11/2023
1	Splenectomy 04/2022
1	Ambulatory Care (Outpatient Care) 01/2021